BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johnson DF, Malone LL, Zalwango S, Mukisa Oketcho J, Chervenak KA, Thiel B, Mayanja-Kizza H, Stein CM, Boom WH, Lancioni CL; Tuberculosis Research Unit. Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection. PLoS One 2014;9:e96613. [PMID: 24796677 DOI: 10.1371/journal.pone.0096613] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Salgame P, Geadas C, Collins L, Jones-López E, Ellner JJ. Latent tuberculosis infection--Revisiting and revising concepts. Tuberculosis (Edinb) 2015;95:373-84. [PMID: 26038289 DOI: 10.1016/j.tube.2015.04.003] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 10.6] [Reference Citation Analysis]
2 Weinberg A, Aaron L, Montepiedra G, Sterling TR, Browning R, Mmbaga B, Vhembo T, Naik S, Kabugho E, Masheto G, Pahwa S, Mathad JS, LaCourse SM, McCarthy K, Bradford S, Theron G, Costello D, Zimmer B, Pierre MF, Gausi K, Denti P, Haas DW, Gupta A; IMPAACT P1078 study team. Effects of Pregnancy and Isoniazid Preventive Therapy on M. tuberculosis Interferon Gamma Response Assays in Women with HIV. Clin Infect Dis 2020:ciaa1083. [PMID: 32720695 DOI: 10.1093/cid/ciaa1083] [Reference Citation Analysis]
3 Bhatt K, Verma S, Ellner JJ, Salgame P. Quest for correlates of protection against tuberculosis. Clin Vaccine Immunol 2015;22:258-66. [PMID: 25589549 DOI: 10.1128/CVI.00721-14] [Cited by in Crossref: 83] [Cited by in F6Publishing: 60] [Article Influence: 11.9] [Reference Citation Analysis]
4 Mpande CAM, Steigler P, Lloyd T, Rozot V, Mosito B, Schreuder C, Reid TD, Bilek N, Ruhwald M, Andrews JR, Hatherill M, Little F, Scriba TJ, Nemes E. Mycobacterium tuberculosis-Specific T Cell Functional, Memory, and Activation Profiles in QuantiFERON-Reverters Are Consistent With Controlled Infection. Front Immunol 2021;12:712480. [PMID: 34526988 DOI: 10.3389/fimmu.2021.712480] [Reference Citation Analysis]
5 Chao CC, Lin CJ, Chen HS, Lee TL. Negative Mantoux test in a patient with definite pulmonary and ocular tuberculosis. Taiwan J Ophthalmol 2015;5:182-6. [PMID: 29018695 DOI: 10.1016/j.tjo.2014.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Suliman S, Geldenhuys H, Johnson JL, Hughes JE, Smit E, Murphy M, Toefy A, Lerumo L, Hopley C, Pienaar B, Chheng P, Nemes E, Hoft DF, Hanekom WA, Boom WH, Hatherill M, Scriba TJ. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses. J Immunol 2016;197:1100-10. [PMID: 27412415 DOI: 10.4049/jimmunol.1501996] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 12.5] [Reference Citation Analysis]
7 Foster M, Hill PC, Setiabudiawan TP, Koeken VACM, Alisjahbana B, van Crevel R. BCG-induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next-generation vaccines. Immunol Rev 2021;301:122-44. [PMID: 33709421 DOI: 10.1111/imr.12965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Biraro IA, Egesa M, Kimuda S, Smith SG, Toulza F, Levin J, Joloba M, Katamba A, Cose S, Dockrell HM, Elliott AM. Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study. BMC Infect Dis 2015;15:438. [PMID: 26493989 DOI: 10.1186/s12879-015-1201-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]